Pages that link to "Q28184964"
Jump to navigation
Jump to search
The following pages link to xi-Aminocaproic acid: an inhibitor of plasminogen activation (Q28184964):
Displaying 50 items.
- Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways (Q24634211) (← links)
- Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients (Q28286577) (← links)
- Platelet changes following clinical and experimental hepatic homotransplantation (Q33462427) (← links)
- Coagulation Studies in Haemolytic Uraemic Syndrome (Q33468650) (← links)
- Reduction of canine plasminogen leads to an expanded molecule which precipitates (Q33480978) (← links)
- Studies on the activation of a serum esterase with ether and its relationship to C'l-esterase (Q34010380) (← links)
- Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products (Q34019757) (← links)
- Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization (Q34019785) (← links)
- The effect of epsilon amino caproic acid and other inhibitors of proteolysis upon the response of human peripheral blood lymphocytes to phytohemagglutinin (Q34061741) (← links)
- Separation of Plasma Thromboplastin Antecedent from Kallikrein by the Plasma α2-Macroglobulin, Kallikrein Inhibitor (Q34064933) (← links)
- Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase (Q34276086) (← links)
- Inhibitors of fibrinolysis in the treatment of haemophilia. (Q34302603) (← links)
- Changes in Blood Coagulation (Q34561581) (← links)
- Histological localization of plasminogen activator and proteolytic activity in the human stomach and duodenum (Q35004792) (← links)
- The interaction of streptococcal enolase with canine plasminogen: the role of surfaces in complex formation (Q35092802) (← links)
- Factor VIII recombination after dissociation by CaCl12. (Q35110177) (← links)
- Population pharmacokinetics of ϵ-aminocaproic acid in adolescents undergoing posterior spinal fusion surgery (Q35189432) (← links)
- Studies on the thrombolytic activity of human plasma (Q35564843) (← links)
- Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins (Q35566578) (← links)
- Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization (Q35568955) (← links)
- C1 inactivator inhibition by plasmin (Q35575716) (← links)
- A primate model of hyperacute renal allograft rejection (Q35878367) (← links)
- Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury (Q35897802) (← links)
- Prevention by hydrocortisone of changes in connective tissue induced by an excess of vitamine A acid in Amphibia. (Q38633335) (← links)
- STUDIES ON THE PATHOGENESIS OF ACUTE INFLAMMATION. V. AN ASSESSMENT OF FACTORS THAT INFLUENCE IN VITRO THE PHAGOCYTIC AND ADHESIVE PROPERTIES OF LEUKOCYTES OBTAINED FROM RABBIT PERITONEAL EXUDATE (Q38633549) (← links)
- Hyperacute renal allograft rejection in the primate. Therapeutic limitations of antiplatelet agents alone and combined with heparin (Q36077484) (← links)
- Some effects of proteolytic inhibitors on tissue injury and systemic anaphylaxis (Q36265310) (← links)
- Anaphylaxis in chopped guinea pig lung. II. Enhancement of the anaphylactic release of histamine and slow reacting substance by certain dibasic aliphatic acids and inhibition by monobasic fatty acids (Q36265363) (← links)
- Destruction of epidermal cells in vitro by autologous serum from normal animals (Q36265790) (← links)
- The enhancement of chloroform-induced plasma proteolytic activity by epsilon aminocaproic acid (Q36265914) (← links)
- Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro (Q36269052) (← links)
- Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein (Q36270035) (← links)
- The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator (Q36272174) (← links)
- Alveolar osteitis following surgical removal of mandibular third molars (Q36309614) (← links)
- The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases (Q36632949) (← links)
- COAGULATION AND FIBRINOLYSIS IN INJURED PATIENTS. (Q36725711) (← links)
- Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery (Q36963877) (← links)
- Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage (Q37014498) (← links)
- Isolation of alpha 1-protease inhibitor from human normal and malignant ovarian tissue (Q37026191) (← links)
- Full time course kinetics of the streptokinase-plasminogen activation pathway (Q37226126) (← links)
- Plasmin-mediated proteolysis of casein in bovine milk (Q37330307) (← links)
- Studies on the proteolytic activity of gamma-globulin preparations (Q39261855) (← links)
- Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin (Q39449655) (← links)
- Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin (Q39729130) (← links)
- Basis of antifibrinolytic therapy (Q40098863) (← links)
- Pesticins. 3. Expression of coagulase and mechanism of fibrinolysis (Q40121145) (← links)
- Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. III. Demonstration of abnormal clot structure by electron microscopy (Q40319156) (← links)
- Actie Hageman factor: a plasma lysokinase of the human fibrinolytic system (Q40319431) (← links)
- The mechanism of clot dissolution by plasmin (Q40330962) (← links)
- Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes (Q40528276) (← links)